Estrella Immunopharma Inc.

ESLA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.63

-$0.10 (-13.54%)

At close: Oct 30, 2026, 3:59 PM ET

$0.67

+$0.04 (+6.03%)

Pre-market: Nov 2, 2026, 6:48 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $27.23M

Enterprise Value $27.08M

Beta 0.93

Average Volume 1.2M

Shares Outstanding (Diluted) 43M

Shares Change YoY 18.89%

Institutional Ownership 12.30%

Exchange NASDAQ

ISIN US2975841048

Price Performance

Price Change 1M 35.0%

Price Change 3M -11.7%

Price Change 6M -61.4%

Price Change YTD -59.6%

Price Change 1Y -74.0%

Price Change 3Y -60.6%

Price Change 5Y -93.7%

1M CAGR (ann.) 20.9%

1Y CAGR (ann.) -74.0%

5Y CAGR (ann.) -42.2%

All-Time CAGR -41.2%

Valuation

PE Ratio -2.52

Forward PE N/A

PEG Ratio -0.14

Forward PEG 0.04

PS Ratio N/A

Forward PS N/A

PB Ratio -3.66

P/FCF Ratio -2.90

P/Adj. FCF Ratio -2.77

P/OCF Ratio -2.86

EV/Sales N/A

EV/EBIT -2.77

EV/EBITDA -2.77

EV/FCF -2.89

Earnings Yield -39.7%

FCF Yield -34.5%

Adj. FCF Yield -36.1%

Financial Health

Net Cash $146.67K

Total Debt $0

Cash & Short-Term Investments $146.67K

Total Assets $1.82M

Current Ratio 0.20

Quick Ratio 0.20

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -52.70

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -4.8%

Returns

Return on Assets -548.7%

Return on Equity 121.7%

Return on Invested Capital 131.8%

Return on Capital Employed 131.8%

Return on Tangible Assets -548.7%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -7.6%

EPS CAGR 5Y -17.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y 66.7%

FCF CAGR 5Y -22.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Dec 2, 2026

EPS Estimate (next Q) -$0.08

EPS Growth Est (next Q) -38.5%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $8.00

Price Target Upside 1169.8%

Cash Flow

Operating Cash Flow $-9.38M

Free Cash Flow $-9.38M

Adj. Free Cash Flow $-9.83M

FCF Per Share -$0.22

OCF Per Share -$0.22

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-9.79M

EBITDA $-9.79M

Net Income $-10.01M

EPS (Diluted) -$0.25

Revenue / Employee N/A

Profit / Employee $-3.34M

Employees 3